CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
CSL Limited Company Snapshot
CSL Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares CSL Limited with three other pharmaceutical manufacturers in Australasia: Probiotec Limited (2020 sales of 107.22 million Australian Dollars [US$75.88 million] ), AFT Pharmaceuticals Ltd of NEW ZEALAND (105.60 million New Zealand Dollars [US$69.15 million] of which 58% was Australia), and Mayne Pharma Group Limited (457.77 million Australian Dollars [US$323.97 million] of which 55% was Generic Products).

Sales Analysis. CSL Limited reported sales of A$13.65 billion (US$9.66 billion) for the fiscal year ending June of 2020. This represents an increase of 14.3% versus 2019, when the company's sales were A$11.95 billion. Sales at CSL Limited have increased during each of the previous five years (and since 2015, sales have increased a total of 101%). Sales of Seqirus saw an increase of 18.9% in 2020, from A$1.42 billion to A$1.69 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
CSL Limited
  Stock Performance Chart for CSL Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 282.62
(Figures in Australian Dollars)
1 Week -0.3%   13 Weeks -4.4%  
4 Weeks -2.0%   52 Weeks 20.5%  
 
CSL Limited Key Data:
  Ticker: CSL Country: Australia
  Exchanges: FRA OTC ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 13,652,444,552
(Year Ending Jan 2021).
Employees: 27,000
  Currency: Australian Dollars Market Cap: 128,323,245,572
  Fiscal Yr Ends: June Shares Outstanding: 454,048,707
  Share Type: Ordinary Closely Held Shares: 1,259,382
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.